X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (63) 63
female (45) 45
male (45) 45
middle aged (38) 38
gastroenterology & hepatology (36) 36
adult (33) 33
index medicus (30) 30
aged (28) 28
life sciences (16) 16
prospective studies (16) 16
antiviral agents - therapeutic use (15) 15
liver cirrhosis - complications (15) 15
cancer (14) 14
treatment outcome (14) 14
cirrhosis (13) 13
hepatitis c, chronic - drug therapy (12) 12
liver cirrhosis (12) 12
prognosis (12) 12
hepatitis c (11) 11
infection (11) 11
human health and pathology (10) 10
liver (10) 10
liver cirrhosis - mortality (10) 10
liver cirrhosis - virology (10) 10
retrospective studies (10) 10
risk factors (10) 10
abridged index medicus (9) 9
diagnosis (9) 9
hepatitis b (9) 9
hepatitis c virus (9) 9
interferon-alpha - therapeutic use (9) 9
management (9) 9
therapy (9) 9
france (8) 8
france - epidemiology (8) 8
gastroenterology and hepatology (8) 8
hepatitis (8) 8
liver cancer (8) 8
patients (8) 8
pregnancy (8) 8
virus-infection (8) 8
analysis (7) 7
hepatitis c, chronic - complications (7) 7
hepatocellular-carcinoma (7) 7
hépatology and gastroenterology (7) 7
infections (7) 7
risk (7) 7
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (6) 6
care and treatment (6) 6
follow-up studies (6) 6
incidence (6) 6
infectious diseases (6) 6
liver cirrhosis - drug therapy (6) 6
mortality (6) 6
proportional hazards models (6) 6
recombinant proteins (6) 6
ribavirin - therapeutic use (6) 6
survival rate (6) 6
time factors (6) 6
aged, 80 and over (5) 5
anrs co12 cirvir (5) 5
anti-bacterial agents - therapeutic use (5) 5
antiviral agents - administration & dosage (5) 5
bacterial infections (5) 5
biopsy (5) 5
disease (5) 5
drug therapy, combination (5) 5
health aspects (5) 5
hepatitis b virus (5) 5
hepatitis b, chronic - drug therapy (5) 5
interferon (5) 5
liver neoplasms - mortality (5) 5
medicine (5) 5
multivariate analysis (5) 5
oncology (5) 5
ribavirin - administration & dosage (5) 5
risk assessment (5) 5
risk-factors (5) 5
sensitivity and specificity (5) 5
severity of illness index (5) 5
survival analysis (5) 5
viral load (5) 5
virology (5) 5
[ sdv.mhep.heg ] life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
antiviral agents - adverse effects (4) 4
ascites - complications (4) 4
ascitic fluid (4) 4
carcinoma, hepatocellular - epidemiology (4) 4
carcinoma, hepatocellular - mortality (4) 4
cell biology (4) 4
chronic hepatitis-c (4) 4
digestive system diseases (4) 4
disease progression (4) 4
dna (4) 4
dose-response relationship, drug (4) 4
double-blind (4) 4
double-blind method (4) 4
fluorodeoxyglucose f18 (4) 4
hematology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2016, Volume 152, Issue 1, pp. 142 - 156.e2
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 04/2015, Volume 15, Issue 4, pp. 397 - 404
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 5, pp. 1047 - 1055
Background & Aims Simeprevir (SMV) is a once-daily (QD), oral hepatitis C virus (HCV) NS3/4A protease inhibitor approved for treatment of genotype (GT) 1 and... 
Gastroenterology and Hepatology | Simeprevir | Chronic | Response-guided | Efficacy | Safety | TMC435 (10/10) | Hepatitis C virus | Sustained virologic response | Protease inhibitor | Genotype 4 | PLUS RIBAVIRIN | MONOTHERAPY | CHRONIC HEPATITIS-C | PHASE-3 | SUSTAINED VIROLOGICAL RESPONSE | THERAPY | PEGINTERFERON ALPHA-2B | DOUBLE-BLIND | INTERFERON-ALPHA 2A | GASTROENTEROLOGY & HEPATOLOGY | ONCE-DAILY TMC435 | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | Hepatitis C, Chronic - ethnology | Secondary Prevention | Recombinant Proteins - adverse effects | Simeprevir - adverse effects | Simeprevir - administration & dosage | Ribavirin - administration & dosage | Female | Hepacivirus - drug effects | Drug Administration Schedule | RNA, Viral - analysis | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Interferon-alpha - adverse effects | Viral Load - drug effects | Viral Load - methods | Genetic aspects | Protease inhibitors | Hepatitis C | Proteases | Health aspects
Journal Article
Gastroenterology, ISSN 0016-5085, 11/2018, Volume 155, Issue 5, pp. 1436 - 1450.e6
Journal Article
Pan African Medical Journal, ISSN 1937-8688, 2015, Volume 20
Journal Article
Pan African Medical Journal, ISSN 1937-8688, 2015, Volume 20
Journal Article
Gastroenterology, ISSN 0016-5085, 12/2018, Volume 155, Issue 6, pp. 1816 - 1827.e9
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article